Skip to content

The effects of triacylglycerol structure of palmitic acid rich fats on postprandial changes in lipid and glucose metabolism

The effects of triacylglycerol structure of palmitic acid rich fats on postprandial changes in lipid and glucose metabolism - Dietary fats and postprandial metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33469
Enrollment
28
Registered
2009-03-30
Start date
2009-04-08
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disturbances during the postprandial state metabolic disturbances after a meal

Interventions

All subjects will receive four meals in a random order, a meal rich in palm olein, interesterified palm olein, lard, or high-oleic acid sunflower oil (control).

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Body mass index (BMI) between 20-35 kg/m2 Age: 18-45 years Serum total cholesterol

Exclusion criteria

Exclusion criteria: -Smoking -(Drug treatment against) Diabetes Mellitus -Cardiovascular disease -Familial hypercholesterolemia or lipid-lowering medication -Diseases that can interfre with the outcome of the studies such as: COPD, asthma, epilepsy, IBD, reumatoid arthritis -Unstable body weight (>3 kg weight gain or weight loss during the past 3 months) -Abuse of drugs or alcohol (>28 consumptions a week) -Participation in another trial or use of experimental products during the last months -Having donated blood during the last two months -Difficult or impossible to puncture during screening -Not willing to consume animal-derived products

Design outcomes

Primary

MeasureTime frame
Metabolic risk markers related to cardiovascular disease: Primary endpoints are postprandial lipemia and glycemia.

Secondary

MeasureTime frame
Secondary endpoints are changes in postprandial concentrations of insulin, and factors related to low-grade systemic inflammation and clotting activity, and of gut hormones.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)